Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The device applies substances directly to body tissues, improving cell transplant and treatment processes.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Changing hairstyles can prevent hair loss caused by tension.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Ift20 is essential for hair follicle function and skin cell movement.

The mTurq2-Col4a1 mouse model shows that cells can divide while attached to stable basement membranes during development.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

A brain injury can lead to compulsive hair-pulling and psychosis-like symptoms, needing comprehensive treatment.

A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Topical tofacitinib is effective and safe for treating alopecia areata.

Trichotillomania requires combined dermatology and psychiatry care for better management and quality of life.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Activated LEF/TCF complexes are crucial for hair development and cycling.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Megasessions in hair transplant can cover more area or increase density but need a skilled team and careful planning, and have both benefits like less downtime and risks like lower graft survival.